Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alexion, Ascendis, BMS, Idorsia, Incyte, Karyopharm, Novartis, Xeris.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Nexstim.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Boehringer Ingelheim, Genentech, GSK, Lilly, Mesoblast, Mind Medicine, Momenta, Novartis, Oryzon, Regeneron, Sanofi, Sinovac, UCB, Veloxis.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agendia, Zhejiang Orient Gene Biotech.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Adial, Affimed, Amag, Biosig, Indivior, Inovio, Magenta, Novavax, Nucleus, PDS, Roivant, Sunovion, Vir.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cytosorbents, Nanostring, Pathnostics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ansun, Arvinas, Cytodyn, Gensight, Ico, Mallinckrodt, Oragenics.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aslan, Bausch Health, Biocryst, Bridge, Eli Lilly, Firstwave, Fujifilm, Kazia, Laurent, Mesoblast, Neuclone, Viriom.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Impulse Dynamics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aldeyra, Amgen, Astrazeneca, Beigene, Bioinvent, Calithera, Cytokinetics, Healios, Madrigal, Outlook.